Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
Clinical trial NCT06377930 · COMPLETED
Trial details
- NCT number
- NCT06377930
- Sponsor
- Rapport Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2025-09-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.